BRIEF-Cns Pharmaceuticals Announces Reverse Stock Split

Reuters2022-11-29

Nov 28 (Reuters) - CNS Pharmaceuticals Inc :

* CNS PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT

* CO ANNOUNCED A 1-FOR-30 REVERSE SPLIT OF ITS COMMON STOCK

* CBEGINNING ON NOV 29, CO'S COMMON STOCK WILL CONTINUE TO TRADE ON NASDAQ ON SPLIT ADJUSTED BASIS UNDER TRADING SYMBOL "CNSP"

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2287124865?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-11-29 05:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2287124865","market":"us","top_or_hot":-1,"title":"BRIEF-Cns Pharmaceuticals Announces Reverse Stock Split","media":"Reuters","content":"<html><body><p>Nov 28 (Reuters) - CNS Pharmaceuticals Inc   :</p><p>   * CNS PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT</p><p>   * CO ANNOUNCED A 1-FOR-30 REVERSE SPLIT OF ITS COMMON STOCK</p><p>   * CBEGINNING ON NOV 29, CO'S COMMON STOCK WILL CONTINUE TO TRADE ON NASDAQ ON SPLIT ADJUSTED BASIS UNDER TRADING SYMBOL \"CNSP\"</p><p>Source text for Eikon:    Further company coverage:   </p><p>((Reuters.Briefs@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Cns Pharmaceuticals Announces Reverse Stock Split</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Cns Pharmaceuticals Announces Reverse Stock Split\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-29 05:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 28 (Reuters) - CNS Pharmaceuticals Inc   :   * CNS PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT   * CO ANNOUNCED A 1-FOR-30 REVERSE SPLIT OF ITS COMMON STOCK   * CBEGINNING ON NOV 29, CO'S COMMON...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_MNQ","symbol_name":"微型NQ100指数","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2287124865","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2287124865","pubTimestamp":1669672679,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 28 (Reuters) - CNS Pharmaceuticals Inc   :   * CNS PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TQQQ":"纳指三倍做多ETF","BK4007":"制药","QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","BK4196":"保健护理服务","SANA":"Sana Biotechnology, Inc.","PSQ":"纳指反向ETF","CNSP":"CNS Pharmaceuticals, Inc.","LABP":"Landos Biopharma, Inc.","BK4082":"医疗保健设备","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU1861215975.USD":"贝莱德新一代科技基金 A2","LU1548497426.USD":"安联环球人工智能AT Acc","ON":"安森美半导体","LU1861220033.SGD":"Blackrock Next Generation Technology A2 SGD-H","BK4141":"半导体产品","SQQQ":"纳指三倍做空ETF",".IXIC":"NASDAQ Composite","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","BK4512":"苹果概念","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","CGEM":"Cullinan Oncology, Inc.","QID":"纳指两倍做空ETF","APR":"Apria, Inc.","LHDX":"Lucira Health, Inc.","BK4139":"生物科技"},"translate_title":"简介-中枢神经系统制药公司宣布反向股票分割","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ON":0.9,"CNSP":0.9,"APR":0.64,"LHDX":0.64,"LABP":0.64,"CGEM":0.64,"SANA":0.64,".IXIC":0.64,"QLD":0.6,"QID":0.6,"QQQ":0.6,"PSQ":0.6,"SQQQ":0.6,"TQQQ":0.6,"NQmain":0.6,"MNQmain":0.6},"content_text":"Nov 28 (Reuters) - CNS Pharmaceuticals Inc   :   * CNS PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT   * CO ANNOUNCED A 1-FOR-30 REVERSE SPLIT OF ITS COMMON STOCK   * CBEGINNING ON NOV 29, CO'S COMMON STOCK WILL CONTINUE TO TRADE ON NASDAQ ON SPLIT ADJUSTED BASIS UNDER TRADING SYMBOL \"CNSP\"Source text for Eikon:    Further company coverage:   ((Reuters.Briefs@thomsonreuters.com))","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2287124865"}